おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TrialSpark
company
About
TrialSpark is a technology company that helps bring treatments to patients faster by reimagining how clinical trials are run.
- 101 - 250
Details
- Last Funding Type
- Series Unknown
- Industries
- Biotechnology,Clinical Trials,Health Care
- Founded date
- Jun 1, 2014
- Number Of Employee
- 101 - 250
- Operating Status
- Active
TrialSpark is a technology-driven pharma company that runs end-to-end clinical trials, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial, enabling more efficient trial design, faster trial completion, and higher trial data quality. TrialSpark in-licenses and co-develops drug programs through in-house development, joint ventures, and NewCos.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$156M
TrialSpark has raised a total of
$156M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2021 | Series C | $156M | 1 | — | — | Detail |
| Oct 15, 2018 | Series Unknown | — | 1 | — | — | Detail |
| Sep 28, 2017 | Funding Round | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
TrialSpark is funded by 1 investors.
Sequoia Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Sequoia Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
